Morning Breakouts

Latest California Healthline Stories

CHCF, Robert Wood Johnson Foundation Award $1.2 Million in Grants to Integrated Healthcare Association

The California HealthCare Foundation and the Robert Wood Johnson Foundation have awarded the Integrated Healthcare Association, a California group that addresses health policy and managed care issues, two grants that total more than $1.2 million to conduct pilot programs to help health care providers improve quality.

Davis Approves Physician ‘Bill of Rights’ To Regulate HMO Contracts with Doctors

Gov. Gray Davis (D) yesterday signed into law a bill (AB 2907) that establishes a physician “bill of rights” to “limit health plans’ ability to unilaterally change contract terms” with doctors in the state, the San Diego Union-Tribune reports.

Health Care in San Jose Area Likely To Experience ‘Dramatic Change,’ Mercury News Columnist Writes

Given the demise of San Jose-based health insurer Lifeguard and San Jose/Good Samaritan Medical Group, the city’s largest physician group, “There’s a lot to be afraid of when you survey Silicon Valley’s health care landscape,” San Jose Mercury News columnist Peter Delevett writes.

Frito-Lay Will Stop Using Hydrogenated Oils in Some Snacks Next Year

Snack food company Frito-Lay announced this week that it will stop using trans-fatty, or hydrogenated, oils in its Doritos, Tostitos and Cheetos brand products beginning in early 2003, the Fort Worth Star-Telegram reports.

Federal Trade Commission Requests Documents Detailing Hospital Mergers

The Federal Trade Commission is “demanding” documents related to several mergers between major medical centers as part of its continuing efforts to step up inquiries into possible antitrust violations in the health care industry, the Wall Street Journal reports.

GE Medical System’s New In-Hospital TV Network Raises Concerns about Rx Drug Advertising

The Patient Channel, a new in-hospital television network that was launched yesterday to 50,000 patients, could become a “flash point” in the debate over the “propriety of drug sellers taking their products directly to the public,” the Wall Street Journal reports.